Biontech Se Sponsored Adr (BNTX) has released an update.
BioNTech SE has appointed Annemarie Hanekamp as the new Chief Commercial Officer, starting July 1, 2024. Hanekamp, with over 20 years of experience in the healthcare industry, is set to lead BioNTech’s global commercialization strategy and prepare for the launch of its first oncology product in 2026. Her expertise in commercializing oncology products and a history of successful product launches make her a valuable addition to BioNTech’s management team as they aim to improve cancer treatment options.
For further insights into BNTX stock, check out TipRanks’ Stock Analysis page.
